Jesse Boumelha - Concepedia

Concepedia

Author

Jesse Boumelha

The Francis Crick Institute ORCID

Also Known As

Boumelha, Jesse, J. Boumelha, Jesse Boumelha

93

Publications

1.4K

Citations

10

H-Index

12

Concepts

All Affiliations

The Francis Crick Institute CRUK Lung Cancer Centre of Excellence Institute of Cancer Research Cancer Research UK London Cancer

JB

About

Jesse Boumelha is an author at The Francis Crick Institute specializing in medicine, tumor microenvironment, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	691
2	Cell Biology	1	1	28
3	Immunology	1	1	28
4	Asthma	1	1	663
5	Environmental Lung Diseases	1	1	663

Jesse Boumelha

×

11

Publications

1.4K

Citations

10

H-Index

	Year	Citations
Lung adenocarcinoma promotion by air pollutants William Hill, Emilia L. Lim, Clare E. Weeden, Nature AsthmaLung DepositionEnvironmental Lung DiseasesLung InflammationRespiratory Toxicology	2023	663
RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy Kevin W. Ng, Jesse Boumelha, Katey S.S. Enfield, Nature	2023	240
Therapeutic KRAS <sup>G12C</sup> inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers Edurne Mugarza, Febe van Maldegem, Jesse Boumelha, Science Advances	2022	119
Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis Matthew D. Park, Jessica Le Bérichel, Pauline Hamon, Science	2024	94
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance Deborah R. Caswell, Philippe Gui, Manasi K. Mayekar, Nature Genetics	2023	76
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations Jesse Boumelha, Sophie de Carné Trécesson, Emily K. Law, Cancer Research	2022	73
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward Clinical Cancer Research	2023	36
Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer Meriem Belabed, Matthew D. Park, Cédric M. Blouin, Nature Immunology Cancer ImmunosurveillanceOxysterolMedicineDendritic Cell MaturationImmunology	2025	28
CRISPR–Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer Jesse Boumelha, Andrea de Castro, Nourdine Bah, Cancer Research	2024	25
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade Panayiotis Anastasiou, Christopher Moore, Sareena Rana, Nature Communications	2024	15

Page 1